Home › Funds › Diametric Capital, LP › FLGT

Diametric Capital, LP position in FLGT

FULGENT GENETICS INC · Health Care

Diametric Capital, LP reported holding 697,784 shares of FLGT (FULGENT GENETICS INC) in its Q2 2026 13F filing — a position valued at US$14.3M, representing 1.60% of its reported portfolio and ranking #3 among its reported holdings. Diametric Capital, LP has disclosed FLGT holdings in 6 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)697.78K sh
Reported value held$14.32M
Portfolio Weight1.60%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Diametric Capital, LP's FLGT position evolved

Diametric Capital, LP first disclosed a stake in FLGT in Q4 2024 at 38,818 shares (US$717K). The position peaked in Q2 2026 at 697,784 shares, worth US$14.3M. Across 6 filings, Diametric Capital, LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 697,784 shares valued at US$14.3M — an increase of 336,738 shares quarter over quarter.. Notable position changes include a 43% increase in Q3 2025 (shares rose 16% over the following quarter), a 80% increase in Q1 2026 (shares rose 29% over the following quarter), a 93% increase in Q2 2026 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 38.82K $716.97K New
Q2 2025 168.97K $3.36M New
Q3 2025 241.62K $5.46M Add
Q4 2025 200.16K $5.26M Reduce
Q1 2026 361.05K $5.74M Add
Q2 2026 697.78K $14.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FLGT and 13F data

FLGT (FULGENT GENETICS INC) is a Health Care company. 32 other funds we track also report a position in FLGT — the largest reported positions include Peapod Lane Capital LLC (US$4.6M), Medina Value Partners, LLC (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FLGT

All FLGT fund holders →

FAQ

How long has Diametric Capital, LP held FLGT?

Diametric Capital, LP has disclosed FLGT holdings in 6 of the last 7 reported quarters, going back to Q4 2024.

What is Diametric Capital, LP's current position in FLGT?

As of Q2 2026, Diametric Capital, LP holds 697.78K shares of FLGT (FULGENT GENETICS INC), valued at $14.32M, representing 1.60% of its reported portfolio and ranking #3.

Has Diametric Capital, LP been buying or selling FLGT?

In the latest 13F filing (Q2 2026), Diametric Capital, LP increased its position in FLGT. The position peaked in Q2 2026 at 697.78K shares.

Which other funds hold FLGT?

Other major institutional holders of FLGT include Peapod Lane Capital LLC, Medina Value Partners, LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.